{{Rsnum
|rsid=243021
|Chromosome=2
|position=60357684
|Orientation=minus
|GMAF=0.4982
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 20.4 | 63.7 | 15.9
| HCB | 15.3 | 42.3 | 42.3
| JPT | 10.6 | 39.8 | 49.6
| YRI | 31.3 | 47.6 | 21.1
| ASW | 57.9 | 29.8 | 12.3
| CHB | 15.3 | 42.3 | 42.3
| CHD | 8.3 | 42.2 | 49.5
| GIH | 23.8 | 57.4 | 18.8
| LWK | 44.5 | 46.4 | 9.1
| MEX | 19.0 | 50.0 | 31.0
| MKK | 36.5 | 51.9 | 11.5
| TSI | 29.4 | 45.1 | 25.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20581827
|Trait=Type 2 diabetes
|Title=Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
|RiskAllele=A
|Pval=3E-15
|OR=1.08
|ORtxt=[1.06-1.10]
|OA=1
}}

{{PMID|21278902|OA=1
}} Genetic risk profiling for prediction of type 2 diabetes.

{{PMID|21445555}} Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.

{{PMID Auto
|PMID=23462794
|Title=Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}